DEVIDE-Study: Denosumab versus Intavenous Ibandronate - a 24 months retrospective head to head real life study - Baseline Data

Verbundene Inhalte

• Publikationen

• DEVIDE-Study: Denosumab versus Intavenous Ibandronate - a 24 months retrospective head to head real life study - Baseline Data

  Publikation: Beitrag in Fachzeitschrift › Konferenzabstract